EHAVE, Inc. (EHVVF) Stock

About EHAVE, Inc.

Established in 2011 and headquartered in Miami, Florida, EHAVE, Inc. is a healthcare company concentrating on the development of medical psychedelics and an integrated mental health data platform. This platform is designed to work with both the company's proprietary and third-party digital assessment and therapeutic applications, primarily in Canada. EHAVE provides clinically validated digital rehabilitation and assessment software for patients, including its MegaTeam and Ninja Reflex products. Furthermore, it adapts various custom and third-party clinically proven digital solutions to enhance patient engagement and data modeling. A significant offering is the Ehave Dashboard, a mental health informatics platform that empowers clinicians to make objective, data-driven decisions through insights powered by blockchain technology. The company also offers a platform enabling medical practitioners to deliver healthcare services to patients in their homes. Its comprehensive technology solutions are utilized by clinicians, patients, researchers, pharmaceutical firms, and payors.

EHAVE, Inc. (EHVVF) stock trades at $0.00 with a market capitalization of $323614. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.12, reflecting a net loss over the last twelve months, a negative price-to-book of -0.16, reflecting negative shareholders' equity, price-to-sales of 678.89. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, EHAVE, Inc. generates a return on equity (ROE) of 28.57% (not meaningful, as shareholders' equity is negative), return on capital employed of 21.10%, an operating margin of -91275.18%.

Official website: www.ehave.com